These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12469181)

  • 1. Cellular signaling pathways affect the function of ribonucleotide reductase mRNA binding proteins: mRNA stabilization, drug resistance, and malignancy (Review).
    Burton TR; Kashour T; Wright JA; Amara FM
    Int J Oncol; 2003 Jan; 22(1):21-31. PubMed ID: 12469181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
    Hurta RA; Wright JA
    J Cell Physiol; 1994 Jan; 158(1):187-97. PubMed ID: 7505277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.
    Fan H; Villegas C; Huang A; Wright JA
    Cancer Res; 1996 Oct; 56(19):4366-9. PubMed ID: 8813126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered regulation of message stability and tumor promoter-responsive cis-trans interactions of ribonucleotide reductase R1 and R2 messenger RNAs in hydroxyurea-resistant cells.
    Amara FM; Hurta RA; Huang A; Wright JA
    Cancer Res; 1995 Oct; 55(20):4503-6. PubMed ID: 7553616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1992 Sep; 152(3):529-35. PubMed ID: 1506411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cis-trans interaction at the 3'-untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2, and TGF-beta 3.
    Amara FM; Smith GM; Kuschak TI; Takeuchi TL; Wright JA
    Biochem Biophys Res Commun; 1996 Nov; 228(2):347-51. PubMed ID: 8920917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
    Hurta RA; Wright JA
    J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of transforming growth factor beta signaling in messenger RNA stability.
    Dibrov A; Kashour T; Amara FM
    Growth Factors; 2006 Mar; 24(1):1-11. PubMed ID: 16393690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of mammalian ribonucleotide reductase R1 mRNA stability is mediated by a ribonucleotide reductase R1 mRNA 3'-untranslated region cis-trans interaction through a protein kinase C-controlled pathway.
    Chen FY; Amara FM; Wright JA
    Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):125-32. PubMed ID: 8067998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation.
    Fan H; Villegas C; Huang A; Wright JA
    Cancer Res; 1998 Apr; 58(8):1650-3. PubMed ID: 9563477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transforming growth factor-beta 1 responsive cytoplasmic trans-acting factor binds selectively to the 3'-untranslated region of mammalian ribonucleotide reductase R2 mRNA: role in message stability.
    Amara FM; Chen FY; Wright JA
    Nucleic Acids Res; 1993 Oct; 21(20):4803-9. PubMed ID: 8233829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.
    Cao MY; Lee Y; Feng NP; Xiong K; Jin H; Wang M; Vassilakos A; Viau S; Wright JA; Young AH
    Clin Cancer Res; 2003 Oct; 9(12):4553-61. PubMed ID: 14555530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells.
    Kuo ML; Kinsella TJ
    Cancer Res; 1998 May; 58(10):2245-52. PubMed ID: 9605773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the ribonucleotide reductase small subunit (R2) in the yellow fever mosquito, Aedes aegypti.
    Pham DQ; Kos PJ; Mayo JJ; Winzerling JJ
    Gene; 2006 May; 372():182-90. PubMed ID: 16530987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
    Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
    J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranscriptional regulation of ribonucleotide reductase R1 gene expression is linked to a protein kinase C pathway in mammalian cells.
    Chen FY; Amara FM; Wright JA
    Biochem Cell Biol; 1994; 72(7-8):251-6. PubMed ID: 7893463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining a novel cis-element in the 3'-untranslated region of mammalian ribonucleotide reductase component R2 mRNA. cis-trans-interactions and message stability.
    Amara FM; Sun J; Wright JA
    J Biol Chem; 1996 Aug; 271(33):20126-31. PubMed ID: 8702735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-Catenin stabilizes cyclooxygenase-2 mRNA by interacting with AU-rich elements of 3'-UTR.
    Lee HK; Jeong S
    Nucleic Acids Res; 2006; 34(19):5705-14. PubMed ID: 17040897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
    Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
    Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human R1 subunit of ribonucleotide reductase (RRM1): 5' flanking region of the gene.
    Parker NJ; Begley CG; Fox RM
    Genomics; 1994 Jan; 19(1):91-6. PubMed ID: 8188248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.